GENECENTRIC THERAPEUTICS
GeneCentric Therapeutics engages in developing and commercializing molecular diagnostic tests for oncologists and patients. The company currently has two unique platform technologies including The Lung Subtype Platform (LSP) stratifies lung cancer patients into subtypes, which are important for appropriate therapeutic selection. The first application of LSP was licensed to and independently developed by Laboratory Corporation of America Holdings (“LabCorp”) and is now available through its s... pecialty testing business, Integrated Oncology, as HistoPlusSM: Lung Cancer. Its second platform technology is the Hypoxia Signature which has the potential to identify patients that respond to anti-angiogenesis therapies. GeneCentric utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and, most importantly, patients. The company was incorporated in 2011 and is based in Durham, North Carolina.
GENECENTRIC THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2011-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.genecentric.com
Total Employee:
11+
Status:
Active
Contact:
919-215-5962
Email Addresses:
[email protected]
Total Funding:
38.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving Wordpress Plugins
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-08-15 | Select ImmunoGenomics | Select ImmunoGenomics acquired by GeneCentric Therapeutics | N/A |
Investors List
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - GeneCentric Therapeutics
IAG Capital Partners
IAG Capital Partners investment in Series B - GeneCentric Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - GeneCentric Therapeutics
LabCorp
LabCorp investment in Series B - GeneCentric Therapeutics
Dow Jones
Dow Jones investment in Series A - GeneCentric Therapeutics
Hatteras Venture Partners
Hatteras Venture Partners investment in Seed Round - GeneCentric Therapeutics
Official Site Inspections
http://www.genecentric.com
- Host name: 44.0.153.160.host.secureserver.net
- IP address: 160.153.0.44
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "GeneCentric Therapeutics"
About Us - GeneCentric
Prior to joining GeneCentric, Dr. Milburn was the CSO at Metabolon since 2005, leading the development and growth of the company’s successful research and development organization. …See details»
GeneCentric – Translating the Complexity of Tumor …
GeneCentric collaborates with some of the world’s leading research and development organizations and commercial reference labs. By bringing together our unique strengths and proprietary technology for RNA-based diagnostics, …See details»
GeneCentric Therapeutics, Inc. | LinkedIn
GeneCentric was founded based on intellectual property from Drs. Neil Hayes and Chuck Perou’s laboratories at the Lineberger Comprehensive Cancer Center at the UNC School of Medicine.See details»
GeneCentric Therapeutics - Crunchbase Company Profile & Funding
GeneCentric Therapeutics engages in developing and commercializing molecular diagnostic tests for oncologists and patients. The company currently has two unique platform technologies …See details»
GeneCentric's Leadership Team - Team members and org chart
About. GeneCentric's Leadership Team includes Philippe Chemla and 11 others. Team members. Chenyqua Shepard. Chief Operating OfficerSee details»
GeneCentric - The Org
GeneCentric utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and, most importantly, patients.See details»
Our Technology - GeneCentric
GeneCentric’s leading-edge rT(I)ME Explorer Platform. The rT(I)ME Explorer Platform is translating tumor biology into robust prognostic and predictive RNA-based gene signatures. Our platform builds upon the pioneering work of co …See details»
GeneCentric Diagnostics - VentureRadar
Founded in 2011, GeneCentric is dedicated to enabling precise and effective treatment options for cancer patients through personalized molecular diagnostic assays and targeted drug …See details»
GeneCentric Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore GeneCentric Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 19 news, and 18 literature.See details»
GeneCentric Therapeutics - Funding, Financials, Valuation
GeneCentric Therapeutics is funded by 5 investors. IAG Capital Partners and Hatteras Venture Partners are the most recent investors. GeneCentric Therapeutics has a post-money valuation …See details»
GeneCentric 2025 Company Profile: Valuation, Funding
GeneCentric was founded in 2011. Where is GeneCentric headquartered? GeneCentric is headquartered in NC. What is the size of GeneCentric? GeneCentric has 12 total employees. …See details»
Diagnostics - GeneCentric
A growing portfolio of RNA-based cancer diagnostics . Many tumor types share common molecular subtypes, allowing us to leverage these characteristic subtypes to identify candidate …See details»
GeneCentric Therapeutics Company Profile - Office Locations
GeneCentric Therapeutics has 5 employees at their 1 location and $6.11 m in total funding,. See insights on GeneCentric Therapeutics including office locations, competitors, revenue, …See details»
GeneCentric Therapeutics - Overview, News & Similar companies ...
GeneCentric Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting DURHAM, N.C.--(BUSINESS WIRE)-- #GeneCentric- …See details»
GeneCentric Therapeutics Appoints Prasanth Reddy and Don …
Nov 14, 2023 GeneCentric Therapeutics, Inc. is an RNA-based genomic solutions provider based in Durham, North Carolina. The company designed its technologies to parse the …See details»
GeneCentric - teaserclub.com
GeneCentric Diagnostics is focused on developing and commercializing molecular diagnostic tests aimed at enhancing cancer treatment for oncologists and patients. The company has …See details»
Contact Us - GeneCentric
Please complete the short form below to get in touch with us. Your message will be routed automatically to the appropriate team member.See details»
GeneCentric Therapeutics Identifies RNA-Based Genomic Markers …
Dec 21, 2021 GeneCentric Therapeutics, Inc. is an RNA-based genomic solutions provider based in Durham, North Carolina. The company designed its technologies to parse the …See details»
DNA organization offers clues for advancing stem cell therapy
1 day ago DNA organization offers clues for advancing stem cell therapy. by Iqbal Pittalwala, University of California - Riverside. Stem cells (shown as small balls) can be imagined to roll …See details»
Our Science - GeneCentric
By applying the rT(I)ME Explorer Platform to specific types of cancer and drug response settings, GeneCentric has developed and is expanding its pipeline of cancer subtypes and biomarkers …See details»